[go: up one dir, main page]

NO20042126L - Syntese av 2-aralkoksyadenosiner og 2-alkoksyadenosiner - Google Patents

Syntese av 2-aralkoksyadenosiner og 2-alkoksyadenosiner

Info

Publication number
NO20042126L
NO20042126L NO20042126A NO20042126A NO20042126L NO 20042126 L NO20042126 L NO 20042126L NO 20042126 A NO20042126 A NO 20042126A NO 20042126 A NO20042126 A NO 20042126A NO 20042126 L NO20042126 L NO 20042126L
Authority
NO
Norway
Prior art keywords
aralkoxyadenosines
alkoxyadenosines
synthesis
Prior art date
Application number
NO20042126A
Other languages
English (en)
Other versions
NO326625B1 (no
Inventor
Allan Ray Moorman
Original Assignee
King Pharmaceuticals Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by King Pharmaceuticals Res & Dev filed Critical King Pharmaceuticals Res & Dev
Publication of NO20042126L publication Critical patent/NO20042126L/no
Publication of NO326625B1 publication Critical patent/NO326625B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • C07H19/167Purine radicals with ribosyl as the saccharide radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • C07H19/173Purine radicals with 2-deoxyribosyl as the saccharide radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20042126A 2001-10-25 2004-05-24 Syntese av 2-aralkoksyadenosiner og 2-alkoksyadenosiner NO326625B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33516901P 2001-10-25 2001-10-25
US37572302P 2002-04-26 2002-04-26
PCT/US2002/034313 WO2003035662A1 (en) 2001-10-25 2002-10-24 Synthesis of 2-aralkoxy adenosines and 2-alkoxyadenosines

Publications (2)

Publication Number Publication Date
NO20042126L true NO20042126L (no) 2004-06-23
NO326625B1 NO326625B1 (no) 2009-01-19

Family

ID=26989581

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20042126A NO326625B1 (no) 2001-10-25 2004-05-24 Syntese av 2-aralkoksyadenosiner og 2-alkoksyadenosiner
NO20083239A NO20083239L (no) 2001-10-25 2008-07-22 Anvendelse av adenosin A2A reseptor agonist for fremstilling av et topisk medikament for å akselerere helingen av et sår

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20083239A NO20083239L (no) 2001-10-25 2008-07-22 Anvendelse av adenosin A2A reseptor agonist for fremstilling av et topisk medikament for å akselerere helingen av et sår

Country Status (13)

Country Link
US (1) US6951932B2 (no)
EP (1) EP1446413A4 (no)
JP (1) JP2005511551A (no)
KR (1) KR20040049001A (no)
CN (1) CN1608076A (no)
AU (1) AU2002336668B2 (no)
BR (1) BR0213557A (no)
CA (1) CA2465264C (no)
IL (2) IL161608A0 (no)
NO (2) NO326625B1 (no)
NZ (1) NZ532541A (no)
PL (1) PL369327A1 (no)
WO (1) WO2003035662A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7342003B2 (en) * 2001-10-25 2008-03-11 King Pharmaceuticals Research And Development, Inc. Synthesis of 2-aralkyloxyadenosines, 2-alkoxyadenosines, and their analogs
US20070232561A1 (en) * 2006-03-31 2007-10-04 Edward Leung Pharmaceutical compositions for promoting wound healing
EP2491928A2 (en) 2007-10-19 2012-08-29 The University of Tokyo Therapeutic agent for vitiligo and method of accelerating pigmentation
US20100324279A1 (en) * 2007-12-20 2010-12-23 Andres Patricia M J Crystal forms of 2-[2-(4-chlorophenyl)ethoxy]adenosine
CN110546261B (zh) 2017-03-29 2023-07-25 中国医学科学院基础医学研究所 小rna及其用于预防和/或治疗纤维增生性病症和/或综合征

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE792155A (fr) 1971-12-01 1973-05-30 Takeda Chemical Industries Ltd Nouveaux derives de l'adenosine et leur procede de production
JPS4911896A (no) 1972-05-15 1974-02-01
JPS4920198A (no) 1972-06-26 1974-02-22
JPS49124096A (no) 1973-03-31 1974-11-27
JPS5053393A (no) 1973-09-18 1975-05-12
US5140015A (en) * 1990-02-20 1992-08-18 Whitby Research, Inc. 2-aralkoxy and 2-alkoxy adenosine derivatives as coronary vasodilators and antihypertensive agents
AU6516494A (en) * 1993-04-15 1994-11-08 New York University Adenosine receptor agonists for the promotion of wound healing

Also Published As

Publication number Publication date
CA2465264C (en) 2010-09-07
CN1608076A (zh) 2005-04-20
IL161608A0 (en) 2004-09-27
PL369327A1 (en) 2005-04-18
US20030199686A1 (en) 2003-10-23
NO20083239L (no) 2004-06-23
AU2002336668B8 (en) 2003-05-06
US6951932B2 (en) 2005-10-04
JP2005511551A (ja) 2005-04-28
NO326625B1 (no) 2009-01-19
NZ532541A (en) 2005-09-30
EP1446413A1 (en) 2004-08-18
WO2003035662A1 (en) 2003-05-01
KR20040049001A (ko) 2004-06-10
EP1446413A4 (en) 2007-10-17
IL161608A (en) 2010-05-31
BR0213557A (pt) 2004-10-26
CA2465264A1 (en) 2003-05-01
AU2002336668B2 (en) 2008-01-10

Similar Documents

Publication Publication Date Title
NO20041975L (no) Bicyklisk oksopyridin og oksopyrimidinderivater
NO20043902L (no) Kontrollert syntese av ziprasidon og sammensetninger derav
DK1417175T3 (da) Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf
NO20042433L (no) Syntese og rensing av valasyklovir
DK1390389T3 (da) Cripto-blokerende antistoffer og anvendelser deraf
DE60212600D1 (de) Audiocodierung und decodierung
NO20033387L (no) Modifiserte antistoffer og fremgangsmåter for anvendelse
NO20041582L (no) Antistoffinhibitorer av GDF-8 og anvendelse derav
NO20041272L (no) Tetracycline derivatives and methods of use thereof
NO20053890D0 (no) Syntese av 4amino-2-butenolklorider og anvendelse derav for fremstilling av 3-cyanokinoliner
AU2002346548A8 (en) Regioisomerically pure oxochlorins and methods of synthesis
IS7467A (is) Lansóprasólfjölgervingar og aðferðir við að framleiða þá
NO20033854L (no) N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse
NO20040390L (no) Krystallinske former VI og VII av atorvastatinkalsium.
NO20044916L (no) Preparater av sulfinylacetamid
NO20011026D0 (no) Matvare og fremgangsmÕte for fremstilling derav
DK2305689T3 (da) Syntese af naturligt forekommende ecteinascidiner og relateredeforbindelser
NO20041968L (no) Anvendelse av cystationin
NO20041187L (no) Metoder og blandinger av nye triazinforbindelser
NO20033506D0 (no) Parasittdrepende preparater og fremgangsmåter for anvendelse
IS7128A (is) Hreinsun á zaleploni og kristölluð form þess
NO20042126L (no) Syntese av 2-aralkoksyadenosiner og 2-alkoksyadenosiner
DK1372652T3 (da) Kombination af docetaxel og flavopiridol
NO20034172L (no) Bisykliske guanidinderivater og terapeutiske anvendelser derav
PT1392670E (pt) Derivados substituidos de c-furan-2-il-metilamina e c-tiofen-2-il-metilamina

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees